GB
The startup specializes in cancer immuno-cell therapy, utilizing advanced cell and gene therapies to enhance the immune system's ability to target and eliminate intractable malignancies. By focusing on these difficult-to-treat cancers, the company aims to provide patients with more effective treatment options that leverage their own immune response.
Fukuoka, Japan
Updated 2 months ago
Funding
Funding not disclosed
Funding rounds are not available yet.
Founders
Founder details are not available yet.
Product
Features
- The startup specializes in cancer immuno-cell therapy, utilizing advanced cell and gene therapies to enhance the immune system's ability to target and eliminate intractable malignancies. By focusing on these difficult-to-treat cancers, the company aims to provide patients with more effective treatment options that leverage their own immune response.